Wockhardt divests nutrition business

Indian drug maker sells nutrition products division to French food company

MUMBAI, India — Indian generic drug maker Wockhardt will sell its nutrition business to France's Danone, the company said Tuesday.

The deal is worth $355 million, according to published reports, and includes brands like Farex, Dexolac, Nusobee and Protinex.

Wockhardt said the deal was part of a strategy to consolidate and rationalize its core operations and focus on its pharmaceutical business.

Login or Register to post a comment.